615.665.7100
Contact Us
For more information about BreatheAmerica, please complete the form below. Someone from the company will respond promptly (all fields required).
Joe Hutts, CEO
Derril Reeves, EVP Development
David Hagaman, EVP Chief Medical Officer
Ron Charpentier, EVP Operations
Derril Reeves, EVP Development
David Hagaman, EVP Chief Medical Officer
Ron Charpentier, EVP Operations
Immunotherapy helps reduce hay fever symptoms in about 85% of people with allergic rhinitis.
About 70% of asthmatics also have allergies.
The annual economic cost of asthma is $19.7 billion. Direct costs make up $14.7 billion of that total, and indirect costs such as lost productivity add another $5 billion.
In a survey of U.S. homes, approximately 25% had levels of dust mites high enough to trigger asthma symptoms.